Plus Therapeutics (PSTV) Non-cash Items (2012 - 2026)
Plus Therapeutics (PSTV) reported Non-cash Items of $109601.0 for Q1 2026, down 44.92% year-over-year from $198986.0 in Q1 2025, and down 84.18% quarter-over-quarter from $692781.0 in Q3 2025.
Plus Therapeutics (PSTV) Non-cash Items (2012 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 14 years of Non-cash Items data on file, last reported at $109601.0 in Q1 2026.
- Non-cash Items for Q1 2026 came in at $109601.0, down 44.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $109601.0 (down 44.92% YoY), and the FY2023 annual result was $7000.0, down 98.96% from the prior year.
- Non-cash Items declined to $109601.0 in Q1 2026 per PSTV's latest filing, from $692781.0 in the prior quarter.
- Over five years, Non-cash Items peaked at $1.4 million in Q2 2023 and troughed at $2000.0 in Q3 2023.
- A 5-year average of $442246.5 and a median of $308724.0 in 2025 frame the typical range for Non-cash Items.
- The sharpest annual moves came in 2022 and 2023: Non-cash Items jumped 739575.84% in 2022, then tumbled 99.66% in 2023.
- A 5-year view of Non-cash Items shows it stood at $671892.0 in 2022, then plunged by 98.96% to $7000.0 in 2023, then surged by 1481.06% to $110674.0 in 2024, then soared by 525.97% to $692781.0 in 2025, then slumped by 84.18% to $109601.0 in 2026.
- Business Quant data shows PSTV's Non-cash Items at $109601.0 in Q1 2026, $692781.0 in Q3 2025, and $308724.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Plus Therapeutics | 34.26 Mn | 19.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109,601.00 |
| Mar 31, 2026 | 109,601.00 |
| Sep 30, 2025 | 692,781.00 |
| Sep 30, 2025 | 692,781.00 |
| Jun 30, 2025 | 308,724.00 |
| Jun 30, 2025 | 308,724.00 |
| Mar 31, 2025 | 198,986.00 |
| Mar 31, 2025 | 198,986.00 |
| Sep 30, 2024 | 110,674.00 |
| Sep 30, 2024 | 110,674.00 |
| Jun 30, 2024 | 103,834.00 |
| Jun 30, 2024 | 103,834.00 |
| Mar 31, 2024 | 84,908.00 |
| Mar 31, 2024 | 84,908.00 |
| Dec 31, 2023 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 1.36 Mn |